Evidence map›Paper›PMID 32966307›Full record

ArticlePloS one2020

"It's hard for us men to go to the clinic. We naturally have a fear of hospitals." Men's risk perceptions, experiences and program preferences for PrEP: A mixed methods study in Eswatini.

Astrid Berner-Rodoreda, Pascal Geldsetzer, Kate Bärnighausen, Anita Hettema, Till Bärnighausen, Sindy Matse, Shannon A McMahon

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Astrid Berner-RodoredaInstitute of Global Health, Ruprecht-Karls-Universität, Heidelberg, Germany.ORCID 0000-0002-5484-890X
Pascal GeldsetzerInstitute of Global Health, Ruprecht-Karls-Universität, Heidelberg, Germany.
Kate BärnighausenInstitute of Global Health, Ruprecht-Karls-Universität, Heidelberg, Germany.
Anita HettemaClinton Health Access Initiative Swaziland, Mbabane, Eswatini.
Till BärnighausenInstitute of Global Health, Ruprecht-Karls-Universität, Heidelberg, Germany.
Sindy MatseEswatini Ministry of Health, Mbabane, Eswatini.
Shannon A McMahonInstitute of Global Health, Ruprecht-Karls-Universität, Heidelberg, Germany.
Heidelberg University · DEHarvard University · USJohns Hopkins University · USMinistry of Health · SZUniversity of the Witwatersrand · ZA

Funding

Institutional Career Development Core (KL2)KL2TR003143 · NCATS · STANFORD UNIVERSITY · PI ASCH, STEVEN M. · 2019 to 2023
$8.7M
NCATS NIH HHS KL2 TR003143
6 · The paper itself

Abstract

Few studies on HIV Pre-Exposure Prophylaxis (PrEP) have focused on men who have sex with women. We present findings from a mixed-methods study in Eswatini, the country with the highest HIV prevalence in the world (27%). Our findings are based on risk assessments, in-depth interviews and focus-group discussions which describe men's motivations for taking up or declining PrEP. Quantitatively, men self-reported starting PrEP because they had multiple or sero-discordant partners or did not know the partner's HIV-status. Men's self-perception of risk was echoed in the qualitative data, which revealed that the hope of facilitated sexual performance or relations, a preference for pills over condoms and the desire to protect themselves and others also played a role for men to initiate PrEP. Trust and mistrust and being able or unable to speak about PrEP with partner(s) were further considerations for initiating or declining PrEP. Once on PrEP, men's sexual behavior varied in terms of number of partners and condom use. Men viewed daily pill-taking as an obstacle to starting PrEP. Side-effects were a major reason for men to discontinue PrEP. Men also worried that taking anti-retroviral drugs daily might leave them mistaken for a person living with HIV, and viewed clinic-based PrEP education and initiation processes as a further obstacle. Given that men comprise only 29% of all PrEP users in Eswatini, barriers to men's uptake of PrEP will need to be addressed, in terms of more male-friendly services as well as trialing community-based PrEP education and service delivery.

Indexed as

MotivationPatient Acceptance of Health CarePre-Exposure ProphylaxisAdolescentAdultAgedAmbulatory Care FacilitiesAnti-HIV AgentsEswatiniFemaleHIV InfectionsHumansMaleMiddle AgedSafe SexYoung AdultAnti-HIV Agents

Identifiers

PMID32966307
PMCPMC7510987
OpenAlexW3088108000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.